More Generic Drugs – More Savings

 

Here’s some good news for a change – Americans are saving money on drugs. The Trump Administration has saved Americans $26 Billion over the last 20 months.

The reason is more approval of generic drugs. In the last 20 months the Trump FDA, under the leadership of Commissioner Scott Gottlieb, has approved an astounding 1,617 generic drugs. These generic drugs are identical to branded versions but sold at commodity prices after patents expire. That’s an incredible 81 generic drugs approved every month on average – a 17% increase over the preceding 20 months.

The Wall Street Journal says the Council on Economic Advisers has calculated the savings from these new generics at $26 Billion. Dr. Gottlieb deserves the credit for this incredible performance. He has put a priority on clearing out an application backlog, raising the priority on drugs where competition is limited, and more. The market for generics can respond to policy changes with some speed because copying a drug is much less onerous than new drug discovery and approval.

America takes a lot of flack for high drug prices but the American generics system is the envy of the world. Nine in 10 prescriptions in the U.S. are cheaper generics, which saved $265 Billion last year. Compare that with 70% generics in Canada and less than half in many European countries.

The U.S. drug industry carries the load for the world when it comes to R & D on developing new drugs. These new drugs are expensive while under patent protection. But eventually prices fall as competition arrives when patents expire. Europe enjoys less price discipline.

The White House notes that “as of August 2018 the relative price of prescription drugs was lower than in December 2016,” which is a dose of reality to anecdotes about skyrocketing costs. Important, too, is the point that patients also “save” from expensive new therapies in the form of extended and improved lives. Affordability is an issue only if a drug exists.

WSJ says no past Administration can boast this record of lowering prices without disrupting medical innovation. Yet President Trump is threatening to blow up this progress with his fixation on importing European price controls. (Trump’s Radical Plan to Lower Medicare Drug Prices)

WSJ concludes, “Naturally, Democrats want to set up a “price gouging” agency that would have roving authority to investigate and fine drug companies that are behaving in ways Democrats don’t like. Their model is the Consumer Financial Protection Bureau. Then again, Mr. Trump has rolled out his own demagoguery at pharma executives. The Administration’s record reveals that the better treatment is more competition.”

As I write this on Thanksgiving weekend, I am thankful for Dr. Gottlieb and his agency’s efforts to increase the number of approved generic drugs and the resulting savings for all Americans.

School Choice Made a Difference

 

The Florida Gubernatorial election is finally over. Democratic candidate Andrew Gillum finally conceded the election to Republican Ron DeSantis after a recount showed DeSantis was still ahead by about 30,000 votes.

Ironically, DeSantis can thank black women for his victory. Yes, there is a solid argument that black women rejected the black candidate Gillum in favor of – their children.

According to CNN exit polling of 3,108 voters, of the roughly 650,000 black women who voted in Florida, 18% or about 117,000 chose DeSantis. This exceeded their support for GOP U.S. Senate candidate Rick Scott (9%). In other words, they selected the Republican gubernatorial candidate but not the Republican senatorial candidate.

William Mattox, director of the Marshall Center for Educational Options at the James Madison Institute, writes in The Wall Street Journal that the reason is school choice.

More than 100,000 low-income students in Florida participate in the Step Up For Students program, which grants tax-credit funded scholarships to attend private schools. Even more students are currently enrolled in the state’s 650 charter schools.

Most Step Up students are minorities whose mothers are registered Democrats. Yet these “school choice moms” split their votes when it comes to protecting their ability to choose where their child goes to school.

Four years ago Governor Rick Scott narrowly won re-election for the same reason. In 2016 more than 10,000 scholarship recipients joined Martin Luther King III in Tallahassee to protest a lawsuit filed by the teachers union in America’s largest-ever school choice rally. Yet, despite this outpouring of minority support for school choice, Mr. Gillum chose to ignore the wishes of minority constituents and instead backed the teachers’ unions who oppose school choice. Black women, and 44% of Latinos, made him pay for this betrayal.

Former Secretary of State Condoleezza Rice has called school choice “the civil rights issue of our time.” Yet Democratic leaders refuse to acknowledge and support school choice even though it is the key to upward mobility in minority children. Politicians who claim to represent the interests of families should take heed of this Florida experience and support the interests of parents who only want what’s best for their children.

False Healthcare Promises

 

Last post we talked about Health Insurance Security. People want to know they will always have access to healthcare.

Democrats have successfully argued that they can provide this by preserving ObamaCare – or at least its provisions for protecting pre-existing conditions. Although I argued last time that this was a false narrative, it was an effective political message – not because it was true but because it provoked the fear of losing your health insurance.

But this status quo of defending ObamaCare will not last. The reality of its failures will become increasingly evident as time goes on. Insurance premiums have doubled for individuals and risen 140% for families. Hospitals and doctors are fleeing ObamaCare networks and 75% of plans are now highly restrictive. A record pace of consolidation among hospitals and physician practices has occurred which only drives up healthcare prices as competition is eliminated. An alternative plan will have to be developed by both parties to show they care about your healthcare.

The Democratic plan is sure to be what Senator Bernie Sanders has called “Medicare for All.” Sanders ran for president in 2016 on a platform of socialism that included this promise for your healthcare. It has gained support from other Progressives in the last two years.

Scott W. Atlas, senior fellow at Stanford’s Hoover Institution, recently weighed in on the false promises of Medicare for All in The Wall Street Journal. Advocates insist that such care is “free” but grownups know there is no such thing as a free lunch.

Atlas says, “The constitution of Britain’s National Health Service (NHS) states: “You have the right to receive NHS services free of charge” – ignoring that the U.K. funds the program by taxing citizens some $160 Billion a year, even with its severe limits on access to specialists, drugs and technology.”

Estimates are that California’s cost alone for single-payer healthcare would exceed $400 Billion a year – more than twice the state’s annual budget. Conservative estimates of the national cost exceed $32 Trillion over the first ten years. Doubling federal income and corporate taxes would be insufficient to cover the expense.

Atlas rightly points out that the problems don’t end with the high cost of single-payer healthcare. The natural reaction of the government to respond to such high expense is to limit access to healthcare. This is done by limiting the number of physicians, limiting the number of appointments, and limiting the approval of costly treatments. This has been the default response of every country where single-payer healthcare exists today.

The result of this denied access to healthcare is predictable. Increased pain, suffering, permanent disability and death are inevitable. The best healthcare in the world is useless if it is unavailable.

Here’s a reality check of waiting times for countries with single-payer systems today:

United Kingdom

  • 2 million patients on the NHS waiting lists
  • 362,600 patients waited longer than four months for hospital treatment as of March last year
  • 95,252 patients waited longer than six months
  • 4,300 patients were on the waiting list more than a year by July
  • 19%of patients wait 2 months or longer to begin their first “urgent” cancer treatment
  • 17% wait more than 4 months for brain surgery

 

Canada

  • The median waiting time between seeing a general practitioner and a specialist was 10.2 weeks.
  • 5 months between seeing a doctor and beginning treatment
  • 3 months to see an ophthalmologist
  • 4 months to see an orthopedist
  • 10 months for orthopedic hip or knee replacement
  • 5 months to see a neurosurgeon
  • 8 months for neurosurgery
  • 3 months for initial treatment of heart disease

 

These excessive waiting times are not only for seeing doctors but also for obtaining diagnostic studies like CT Scans, MRI scans, and heart catheterizations, as well as to obtain the newest drugs for cancer and other serious diseases. Aside from transplants, the Organization for Economic Cooperation and Development (OECD), which compares other countries, states, “waiting lists are not a feature in the United States.”

Of course, these excessive waiting times lead to poorer healthcare outcomes. Single-payer systems have proved inferior to the U.S. in outcomes for almost all serous diseases, including cancer, diabetes, high blood pressure, stroke and heart disease.

While America is considering implementing a single-payer system like Medicare for All, those countries that currently have such a system are backing away from it with increased spending on private care. Sweden has increased its spending on private care for the elderly by 50% in the last decade, abolished its government’s monopoly over pharmacies, and made other reforms. Last year the U.K. spent more than $1 Billion on private care according to the Financial Times. In Denmark patients can now choose a private hospital or a hospital outside the country if their wait time exceeds one month. Canada is also feeling the pressure on excessive waiting times and is increasing spending on private care for relief.

Atlas concludes: “A single-payer “guarantee” is no promise of access to quality medical care. If brought to the U.S., the only reliable promises of single-payer would be worse health care for Americans and higher taxes. America’s poor and middle class would suffer the most from a turn to single-payer because only they would be unable to circumvent the system.”